Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients

Clinical Pharmacology: Advances and Applications

Volumn 2, Issue 1, 2010, Pages 89-93

  di Iorio, Biagio ^a   Cucciniello, Emanuele ^a  

^a Unità Operativa Complessa di nefrologia   (Italy)

Author keywords

Hemodialysis; Lanthanum carbonate; QT dispersion; QT interval

Indexed keywords

ALUMINUM HYDROXIDE; LANTHANUM CARBONATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG DOSE INCREASE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HEMODIALYSIS PATIENT; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; P WAVE; PR INTERVAL; QRS COMPLEX; QT INTERVAL; RESPONSE TIME; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

EID: 77955504629     PISSN: None     EISSN: 11791438     Source Type: Book Series    
DOI: 10.2147/cpaa.s10218     Document Type: Article

References (24)

1. Gussak I, Gussak HM. Sudden cardiac death in nephrology: focus on acquired long QT syndrome. Nephrol Dial Transplant. 2007;22:12-14.
2. Stewart GA, Gansevoort RT, Mark PB, et al. Electrocardiographic abnormalities and uremic cardiomiopathy. Kidney Int. 2005;67:217-226.
3. Morris STW, Galiatsou EG, Stewart GA, et al. QT dispersion before and after hemodialysis. J Am Soc Nephrol. 1999;160-163.
4. Covic A, Diaconita M, Gusbeth-Tatomir P, et al. Hemodialysis increases QT interval but not QTc dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Tranplant. 2002;17:2170-2177.
5. Genovesi S, Dossi C, Viganò MR, et al. Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace. 2008;10:771-777.
6. Palasz A, Czekaj P. Toxicological and cytophysiological aspects of lanthanides action. Acta Biochimica Polonica. 2000;47:1107-1114.
7. Przywara D, Bhave S, Bhave A, et al. Activation of K channels by lanthanum contributes to the block of neurotransmitter release in chick and rat sympathetic neurons. J Membr Biol. 1992;125:155-162.
8. Hutchison AJ, Barnett ME, Krause R, Kwan JTC, Siami GA. Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis. Clin Nephrol. 2009;71:286-295.
9. Shigematsu T. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis. Ther Apher Dial. 2008;12(1):55-61.
10. Glancy JM, Weston PJ, Bhullar HK, et al. Reproducibility and automatic measurement of QT dispersion. Eur Heart J. 1996;17:1035-1039.
11. Straus SMJM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362-367.
12. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J. 1998;19:1391-1400.
13. Dekker JM, Schouten EG, Klootwijk P, et al. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zupten study. Circulation. 1994;90:779-785.
14. Schouten EG, Dekker JM, Meppelink P, et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84:1516-1523.
15. Montanez A, Ruskin JN, Hebert PR. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population. Arch Intern Med. 2004;164:943-948.
16. Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis. 2002;39:834-842.
17. Wu V, Yulin L, Wu K. QT interval dispersion in dialysis patients. Nephrology. 2005;10:109-110.
18. Hentges MJ, Gunderson B W, Lewis MJ. Retrospective analysis of cisapride-induced QT changes in ESRD patients. Nephrol Dial Transplant. 2000;15:1814-1818.
19. Mathis AS, Costeas C, Barone JA. Retrospective analysis of the effects of cisapride on the QT interval and QT dispersion in chronic hemodi-alysis patients. Am J Kidney Dis. 2001;38:1284-1291.
20. Oberg KC, Bauman JL. QT interval prolongation and torsade de punta due to erythromycin lactobionate. Pharmacotherapy. 1995;15: 687-692.
21. Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de punta and sudden death. Drugs. 2002;62:1649-1671.
22. Tong KL, Lau YS, Teo WS. A case series of drug-induced long QT syndrome and torsade de punta. Singapore Med J. 2001;42:566-570.
23. Yang Z, Wang H, Zheng Y, et al. Possible arrhythmiogenic mechanism produced by ibuprofen. Acta Pharm Sinica. 2008;29:421-429.
24. Peitz GJ, Malesker MA, Sojka SG. Aliskerin-induced QT interval prolongation. South Med J. 2009;102:411-412.